Hydrocortison Orion (Hydrocortisone)

Hydrocortison Orion is prescribed for several endocrine and inflammatory conditions where replacement of cortisol or suppression of immune activity is required.

• Adrenal insufficiency, including primary (Addison’s disease) and secondary causes.
• Congenital adrenal hyperplasia requiring glucocorticoid replacement.
• Acute or chronic inflammatory autoimmune disorders such as rheumatoid arthritis or systemic lupus erythematosus.
• Severe allergic reactions or asthma exacerbations unresponsive to standard therapy.
• As adjunct therapy in certain dermatologic or hematologic conditions where systemic corticosteroid effect is desired.

• Hydrocortison Orion delivers hydrocortisone, which diffuses across cell membranes and binds to intracellular glucocorticoid receptors. The receptor‑ligand complex translocates to the nucleus, where it interacts with glucocorticoid response elements on DNA, modulating transcription of anti‑inflammatory proteins and repressing pro‑inflammatory cytokine genes. This genomic effect reduces leukocyte migration, vascular permeability, and immune activation, producing systemic glucocorticoid activity.

Oral hydrocortisone may cause a range of adverse reactions, varying from mild and transient to potentially serious.

Common

• Increased appetite or weight gain.
• Fluid retention leading to mild edema.
• Elevated blood glucose levels, especially in diabetic patients.
• Mood changes such as irritability or insomnia.

Serious

• Severe infection due to immunosuppression.
• Osteoporosis or increased risk of fractures with long‑term use.
• Adrenal suppression causing crisis on abrupt discontinuation.
• Hypertension or worsening of existing cardiovascular disease.

Before initiating Hydrocortison Orion, clinicians should evaluate patient history and monitor for conditions that could be aggravated by systemic glucocorticoids.

• Assess for active infections; treat before starting therapy.
• Screen for diabetes mellitus or impaired glucose tolerance.
• Evaluate bone health, especially in patients at risk for osteoporosis.
• Review psychiatric history, as steroids can exacerbate mood disorders.
• Consider dose adjustment in elderly or frail individuals.
• Counsel about the need for gradual tapering to avoid adrenal insufficiency.

Hydrocortison Orion can alter the pharmacokinetics or pharmacodynamics of several other medicines; careful review of concomitant drugs is recommended.

Avoid

• Strong CYP3A4 inducers such as rifampin, which may reduce hydrocortisone exposure.
• Non‑steroidal anti‑inflammatory drugs (NSAIDs) that increase the risk of gastrointestinal bleeding.
• Anticoagulants like warfarin, where corticosteroids may enhance anticoagulant effect.

Use with caution

• Antidiabetic agents; hydrocortisone may raise blood glucose requiring dose adjustment.
• Antihypertensive drugs; fluid retention can blunt blood pressure control.
• Vaccines, particularly live attenuated types, as immunosuppression may diminish efficacy.